Why the study?
Many traditional cardiovascular risk factors do not predict survival to very old age, leaving the prognostic value of eGFR and NT-pro-BNP levels and trajectories for reaching age 90 unclear.
Are levels and changes in eGFR and NT-pro-BNP associated with survival to age 90 in older adults?
Are levels and changes in eGFR and NT-pro-BNP associated with survival to age 90 in older adults?
Higher baseline eGFR and slower decline, along with lower baseline NT-pro-BNP and slower increase, are significantly associated with longevity to age 90.
Answers are grounded in this paper and cite their sources.
Higher eGFR and lower NT-proBNP were associated with survival to 90; hypothesis-generating for whether modifying these biomarkers extends lifespan in older adults.
BACKGROUND: Many traditional cardiovascular risk factors do not predict survival to very old age. Studies have shown associations of estimated glomerular filtration rate (eGFR) and N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) with cardiovascular disease and mortality in older populations. This study aimed to evaluate the associations of the level and change in eGFR and NT-pro-BNP with longevity to age 90 years. METHOD: The population included participants (n = 3,645) in the Cardiovascular Health Study, aged between 67 and 75 at baseline. The main exposures were eGFR, calculated with the Berlin Initiative Study (BIS) 2 equation, and NT-pro-BNP, and the main outcome was survival to age 90. Mixed models were used to estimate level and change of the main exposures. RESULTS: There was an association between baseline level and change of both eGFR and NT-pro-BNP and survival to 90, and this association persisted after adjustment for covariates. Each 10 mL/min/1.73 m2 higher eGFR level was associated with an adjusted odds ratio (OR) of 1.23 (95% CI: 1.13, 1.34) of survival to 90, and a 0.5 mL/min/1.73 m2 slower decline in eGFR was associated with an OR of 1.51 (95% CI: 1.31, 1.74). A twofold higher level of NT-pro-BNP level had an adjusted OR of 0.67 (95% CI: 0.61, 0.73), and a 1.05-fold increase per year in NT-pro-BNP had an OR of 0.53 (95% CI: 0.43, 0.65) for survival to age 90. CONCLUSION: eGFR and NT-pro-BNP appear to be important risk factors for longevity to age 90.
No takes yet. Share an insight, caveat, or question.
Häberle et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: